- Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
- Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Alector to Participate in Upcoming Healthcare Conferences
- Alector Reports First Quarter 2024 Financial Results and Provides Business Update
- Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
- Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
- FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
- Alector Announces Closing of Public Offering
More ▼
Key statistics
On Wednesday, Alector Inc (ALEC:NSQ) closed at 4.41, 20.49% above the 52 week low of 3.66 set on Nov 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.37 |
---|---|
High | 4.54 |
Low | 4.27 |
Bid | 4.22 |
Offer | 4.85 |
Previous close | 4.34 |
Average volume | 850.79k |
---|---|
Shares outstanding | 96.38m |
Free float | 87.73m |
P/E (TTM) | -- |
Market cap | 418.31m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼